InMed Pharmaceuticals Inc

NASDAQ:INM  
0.29
+0.01 (+3.55%)
7:57:19 PM EDT: $0.31 +0.02 (+6.31%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.02M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$1.79 Million
Adjusted EPS$0.00
See more estimates
10-Day MA$0.28
50-Day MA$0.31
200-Day MA$0.49
See more pivots

InMed Pharmaceuticals Inc Stock, NASDAQ:INM

815 West Hastings Street, Suite 310, Vancouver, British Columbia V6C 1B4
Canada
Phone: +1.604.669.7207
Number of Employees: 13

Description

InMed Pharmaceuticals, Inc. engages in the provision of biopharmaceutical research. It is also involved in cannabinoid-based therapies and a biosynthesis system for the manufacturing of pharmaceutical-grade cannabinoids. It operates through the InMed and BayMedica segments. The company was founded by Christopher Bogart, Sazzad Hossain, Hyder A. Khoja, and Craig D. Schneider on May 19, 1981 and is headquartered in Vancouver, Canada.